Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,000,447 papers from all fields of science
Search
Sign In
Create Free Account
89Zr-bevacizumab
Known as:
(89)Zr-bevacizumab
, Zirconium Zr 89 Bevacizumab
A radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody bevacizumab labeled with the radioisotope zirconium Zr 89 (Zr 89…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Antibodies, Monoclonal, Humanized
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Intravitreal Bevacizumab and Cardiovascular Risk in Patients with Age-Related Macular Degeneration: Systematic Review and Meta-Analysis of Randomized Controlled Trials and Observational Studies
I. Mikačić
,
D. Bosnar
Drug Safety
2016
Corpus ID: 207487565
IntroductionIntravitreal bevacizumab (IVTB) is used to treat age-related macular degeneration (ARMD), although its use is off…
Expand
2014
2014
Occult macular dystrophy with bilateral chronic subfoveal serous retinal detachment associated with a novel RP1L1 mutation (p.S1199P)
Hidenori Takahashi
,
Takaaki Hayashi
,
+7 authors
H. Kawashima
Documenta Ophthalmologica
2014
Corpus ID: 2284992
PurposeThe purpose of this study was to present an atypical case of occult macular dystrophy (OMD) with bilateral chronic…
Expand
Review
2011
Review
2011
Bevacizumab as a Treatment Option for Radiation-Induced Cerebral Necrosis
C. Matuschek
,
E. Bölke
,
+7 authors
W. Budach
Strahlentherapie und Onkologie (Print)
2011
Corpus ID: 31777459
Radiation necrosis of normal CNS tissue represents one of the main risk factors of brain irradiation, occurring more frequently…
Expand
Highly Cited
2011
Highly Cited
2011
Inert coupling of IRDye800CW to monoclonal antibodies for clinical optical imaging of tumor targets
R. Cohen
,
M. Stammes
,
Inge H C de Roos
,
M. Stigter-van Walsum
,
G. Visser
,
G. V. van Dongen
EJNMMI Research
2011
Corpus ID: 515362
BackgroundPhotoimmunodetection, in which monoclonal antibodies [mAbs] are labeled with fluorescent dyes, might have clinical…
Expand
Review
2010
Review
2010
Identifying systemic safety signals following intravitreal bevacizumab: systematic review of the literature and the Canadian Adverse Drug Reaction Database.
J. Micieli
,
A. Micieli
,
Andrew F. Smith
Canadian Journal of Ophthalmology-journal…
2010
Corpus ID: 41492089
OBJECTIVE As the off-label use of intravitreal bevacizumab continues for an increasing number of ocular conditions, a systematic…
Expand
2010
2010
RESULTS OF 1-YEAR FOLLOW-UP EXAMINATIONS AFTER INTRAVITREAL BEVACIZUMAB ADMINISTRATION FOR IDIOPATHIC CHOROIDAL NEOVASCULARIZATION
Maiko Inoue
,
K. Kadonosono
,
+4 authors
A. Arakawa
Retina
2010
Corpus ID: 205651033
Purpose: The purpose of this study was to report the results of 1-year follow-up examinations after intravitreal bevacizumab…
Expand
Highly Cited
2008
Highly Cited
2008
Effect of Subconjunctival Bevacizumab (Avastin) on Experimental Corneal Neovascularization in Guinea Pigs
V. Hurmeric
,
T. Mumcuoğlu
,
Cuneyt Erdurman
,
B. Kurt
,
O. Dagli
,
A. Durukan
Cornea
2008
Corpus ID: 24282651
Purpose: To evaluate the effect of subconjunctival bevacizumab (Avastin) on experimental corneal neovascularization in guinea…
Expand
2008
2008
Vertical VEGF targeting: A combination of ligand blockade with receptor tyrosine kinase inhibition.
A. Bozec
,
F. Gros
,
+6 authors
G. Milano
European Journal of Cancer
2008
Corpus ID: 28811010
2007
2007
Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation.
C. Costagliola
,
M. Romano
,
R. dell’Omo
,
Ugo Cipollone
,
Paolo Polisena
American journal of ophthalmology-glaucoma
2007
Corpus ID: 21194312
2007
2007
Retinale Pigmentepithelrisse nach intravitrealem Bevacizumab bei AMD
D. Kook
,
Armin Wolf
,
+4 authors
M. Ulbig
Der Ophthalmologe
2007
Corpus ID: 116569629
ZusammenfassungHintergrundDie intravitreale Injektion des Antikörpers Bevacizumab zur Behandlung der neovaskulären AMD findet…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE